Taiwan Bio Therapeutics Inc.
3 clinical trials · Sponsor
◉ Watch Taiwan Bio Therapeutics Inc.
| Record | Firm | Date |
|---|---|---|
| Intracoronary Administration of OmniMSC-AMI for Acute ST-segment Elevation Myocardial Infarction Patients (NCT05724576) | Taiwan Bio Therapeutics Inc. | 2023-06-26 |
| Chondrochymal® for Subjects With Knee Osteoarthritis (Knee OA) (NCT05027581) | Taiwan Bio Therapeutics Inc. | 2021-10-13 |
Track Taiwan Bio Therapeutics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.